# Review Result

RESULT: PASS
REVIEW_VERDICT: PASS

## Summary

The downstream PLAN revalidation correctly propagates ANALYSIS.md's corrected R1 evidence tiers. PLAN.md now consistently distinguishes two DEMONSTRATED observations—5/5 misses share the negative-space archetype and §17 states no explicit falsification/search-depth obligation—from HYPOTHESIS H-4, the unproven claim that the contract gap caused the observed misses.

The Executive Summary, RC-1 classification, verdict evidence, I-1 expected-impact language, OS-22 ticket, ordering rationale, validation criteria, risks, and completion criteria all preserve this distinction. OS-22 remains reasonably P1 because it closes a demonstrated and directly editable contract gap, but its recall effect is explicitly hypothetical, paired with controlled measurement, and forbidden from being presented as a proven fix.

## Blocking Findings

None.

## Non-Blocking Findings

None.

## Test Review

No executable validation applies to this documentation-only downstream revalidation. The required evidentiary validation was performed by reading the corrected ANALYSIS.md baseline, FINAL_REVIEW.md finding R1, and the complete current PLAN.md, plus whole-file searches for residual causal-tier language.

## Evidence Checked

- `FINAL_REVIEW.md:14-20`: independently read R1's issue, evidence, and required propagation targets.
- `ANALYSIS.md:149-224`: confirmed the corrected baseline separates DEMONSTRATED 1 (negative-space archetype), DEMONSTRATED 2 (contract coverage gap), and HYPOTHESIS H-4 (the causal link).
- `ANALYSIS.md:362-374,480-487,511-516`: confirmed the root-cause table, limitations, and recommendation priority use the same tiering.
- `PLAN.md:10-22,87-119`: confirmed the Goal and Executive Summary call H-4 a hypothesis, explicitly state that the contract caused stopping is not demonstrated, and require measurement of OS-22's effect.
- `PLAN.md:369-385`: confirmed RC-1 labels only the contract gap DEMONSTRATED and labels its causal link HYPOTHESIS H-4; the five misses are candidate examples, not asserted proven effects.
- `PLAN.md:550-572`: confirmed the Verdict is carried only by DEMONSTRATED observations and expressly excludes H-4 from its basis.
- `PLAN.md:579-630`: confirmed I-1's P1 rationale rests on closing a demonstrated, editable gap while its expected recall effect is a hypothesis that must be measured on a controlled fixture.
- `PLAN.md:856-922`: confirmed the priority matrix and OS-22 ticket preserve `gap DEMONSTRATED / cause H-4`, require effect measurement, and prohibit presenting the intervention as addressing a demonstrated cause.
- `PLAN.md:1105-1166`: confirmed the ordering rationale, validation rows V3-V4, risk R-G, and completion criteria maintain the corrected evidence tier end to end.
- Whole-file searches found no residual `fully established`, `primary cause`, `settled root cause`, or equivalent language treating H-4 as demonstrated. Other causal references are either expressly negated, labeled hypotheses, or concern distinct demonstrated gaps; no unrelated substantive change was apparent.

## Final Decision

PASS. PLAN.md is fully consistent with ANALYSIS.md's corrected evidence tiers, OS-22's priority no longer depends on the old causal overclaim, and the downstream revalidation introduces no blocking G1-G5 violation.
